For Cancer Immunotherapy Patients, a ‘One-Two Punch’ Could Hold Promise

(DGIwire) – Immunotherapy, in which the human immune system is harnessed to treat cancer, has shown great promise but relatively few patients have responded significantly. Among strategies to enhance its power, one of the most intriguing involves so-called “combination” therapies—a “one-two punch” in which immunotherapy is administered along with another type of therapeutic. In recent […]

Giving Immunotherapy and Chemotherapy a Molecular Boost

(DGIwire) – Immunotherapy has shown great promise in cancer care. However, not all patients respond to it—spurring a search for ways to make it more effective. One of the most intriguing strategies involves so-called “combination treatments” in which immunotherapy and chemotherapy are given in tandem with additional agents. In recent years, researchers have identified several […]

3 Challenges Facing Immunotherapy and How RNAi Might Help

(DGwire) – The battle against solid tumors in cancer immunotherapy is engaging some of the brightest minds in medicine. While predictions suggest the immunotherapy market will be worth about $25 billion by 2030, there are still some hurdles to overcome in the effort to improve treatment options, including: Boosting the immune system to fight: As […]

close